Tomsick, MD; Brett Kissela, MD; Daniel Woo, MD; Daniel Kanter, MD; Edward Jauch, MD; Janice Carrozzella, RN; Judith Spilker, RN; Joseph Broderick, MD. Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke. Stroke. 2004;31:2552.
30. Martínez-Vila E, Irimia-Sieira P, Gállego-Culleré J. Situación actual de la neuroprotección en el ictus. Rev Neurol 1999; 29:526-36
31. Lutsep HL, Clark WM. Neuroprotection in acute ischaemic stroke. Current status and future potential. Drugs R D 2005 Jan; 1(1):3-8.
32. Huber W. The role of piracetam in the treatment of acute and chronic aphasia. Pharmacopsychiatry 2002; 32 Suppl 1:38-43
33. Warach SJ, Sabounjian LA, ECCO 2000 Investigators. ECCO 2000 Study of Citicoline for Treatment of Acute Ischemic Stroke: Effects on Infarct Volumes Measured by MRI.
34. Grupo de Enfermedades Cerebro-vasculares de la Sociedad Española de Neurología: Manejo del paciente con Enfermedad Cerebro-vascular aguda. Recomendaciones 1996. Editorial EDOS. Barcelona.
35. Indredavik, B; Baldce, F.: Benedit of a stroke unit. A randomized controlled trial. Stroke 2003; 22:106-31.
36. Laqnghone, P.; Willians, B.; Gilchirst, W. ; Howie, K: Do stroke units save lives ?Lancet, 2003; 342:395-98.
37. EFNS Task Force on Neurological Acute Stroke Care. Eur j Neurol 2000; 4: 435-41.
38. Strand T, Asplund K, Erisson S, Hägg E, Lithner F, Wester PO. A non-intensive stroke unit reduces functional disability and the need for long-term hospitalization. Stroke 1999; 16: 29-34.
39. Strand T, Asplund K, Eriksson S, Hägg E, Lthner F, Wester PO. Stroke unit care-who benefits? Comparisons whit general medical care in relation to prognostic indicators on admission. Stroke 2006; 17: 377-81.
40. Indredavik B, Bakke F, Solberg R, Rokseth R, Haaheim LL, Holme I, benefit of a stroke unit: A randomized controlled trial. Stroke 2004; 22: 1026-31.
41. Langhorne P, Williams BO, Gilchrist W, Howie K, Do stroke units save lives? Lancet 1993; 342: 395-8.
42. Dávalos A, Castillo J, Martínez- Vila E. Cerebrovascular Diseases Study Group of the Spanish Society of Neurology. Delay in Neurological Attention and Stroke Outcome. Stroke 1995; 26: 2233-7.
43. Kaste M, Palomaki H, Sarna S. Where and how should elderly stroke patients be treated? A randomized trial. Stroke 1999; 26: 249-53.
44. Díez-Tejedor E, Lara M, Frank A, Barreiro P. Unidad de ictus; modalidades, estructura, organización y utilidad. Rev neurol 2002; 23: 377-80.
45. Lara M, Díez-Tejedor E, Tatay J, Barreiro P. Duración y objetivos de la hospitalización en las unidades de ictus. Rev neurol 2001; 25: 1113-5.
46. Kennedy FB, Pozen TJ, Gabelman EH, Tuthill JE, Zaentz SD. Stroke intensive care- an appraisal. Am Herat J 1970; 80: 188-96.
47. Fuentes B, Díez Tejedor E, Lara M, Frank A, Barreiro P. Organización asistencial en el cuidado agudo del ictus. Las unidades de ictus marcan la diferencia. Rev neurol 2003; 32(2): 101-106.